AAAAAA

   
Results: 1-22 |
Results: 22
Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core
Authors: Murray, KD Etheridge, CJ Shah, SI Matthews, DA Russell, W Gurling, HMD Miller, AD
Citation: Kd. Murray et al., Enhanced cationic liposome-mediated transfection using the DNA-binding peptide mu (mu) from the adenovirus core, GENE THER, 8(6), 2001, pp. 453-460
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
Authors: Webber, SE Marakovits, JT Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Lee, CA Srinivasan, B Moran, T Ford, CE Brothers, MA Harr, JEV Meador, JW Ferre, RA Worland, ST
Citation: Se. Webber et al., Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 11(20), 2001, pp. 2683-2686
Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm
Authors: Matthews, DA
Citation: Da. Matthews, Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm, J VIROLOGY, 75(2), 2001, pp. 1031-1038
Mitochondrial protein p32 can accumulate in the nucleus (vol 281, pg 1161,2001)
Authors: Brokstad, KA Kalland, KH Russell, WC Matthews, DA
Citation: Ka. Brokstad et al., Mitochondrial protein p32 can accumulate in the nucleus (vol 281, pg 1161,2001), BIOC BIOP R, 283(4), 2001, pp. 1001-1001
Mitochondrial protein p32 can accumulate in the nucleus
Authors: Brokstad, KA Kalland, KH Russell, WC Matthews, DA
Citation: Ka. Brokstad et al., Mitochondrial protein p32 can accumulate in the nucleus, BIOC BIOP R, 281(5), 2001, pp. 1161-1169
Ammonia and toxicity criteria in polluted Onondaga Lake, New York
Authors: Matthews, DA Effler, SW Matthews, CM
Citation: Da. Matthews et al., Ammonia and toxicity criteria in polluted Onondaga Lake, New York, WAT ENV RES, 72(6), 2000, pp. 731-741
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
Authors: Dragovich, PS Zhou, R Webber, SE Prins, TJ Kwok, AK Okano, K Fuhrman, SA Zalman, LS Maldonado, FC Brown, EL Meador, JW Patick, AK Ford, CE Brothers, MA Binford, SL Matthews, DA Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 10(1), 2000, pp. 45-48
Prayer and spirituality
Authors: Matthews, DA
Citation: Da. Matthews, Prayer and spirituality, RHEUM DIS C, 26(1), 2000, pp. 177
The effect of terrigenous inputs on spatial patterns of water quality indicators in South Lake, Lake Champlain
Authors: Effler, SW Brooks, CM Perkins, MG Ohrazda, NK Matthews, DA Johnson, DL Auer, MT Bloomfield, JA Quinn, SO
Citation: Sw. Effler et al., The effect of terrigenous inputs on spatial patterns of water quality indicators in South Lake, Lake Champlain, J GR LAKES, 26(4), 2000, pp. 366-383
Effects of intercessory prayer on patients with rheumatoid arthritis
Authors: Matthews, DA Marlowe, SM MacNutt, FS
Citation: Da. Matthews et al., Effects of intercessory prayer on patients with rheumatoid arthritis, SOUTH MED J, 93(12), 2000, pp. 1177-1186
Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32
Authors: Bryant, HE Matthews, DA Wadd, S Scott, JE Kean, J Graham, S Russell, WC Clements, JB
Citation: He. Bryant et al., Interaction between herpes simplex virus type 1 IE63 protein and cellular protein p32, J VIROLOGY, 74(23), 2000, pp. 11322-11328
Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation
Authors: Reich, SH Johnson, T Wallace, MB Kephart, SE Fuhrman, SA Worland, ST Matthews, DA Hendrickson, TF Chan, F Meador, J Ferre, RA Brown, EL DeLisle, DM Patick, AK Binford, SL Ford, CE
Citation: Sh. Reich et al., Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation, J MED CHEM, 43(9), 2000, pp. 1670-1683
Religious commitment and health status
Authors: Matthews, DA McCollough, ME Swyers, JP Milano, MG Larson, DB Koenig, HG
Citation: Da. Matthews et al., Religious commitment and health status, ARCH FAM M, 8(6), 1999, pp. 476-476
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids
Authors: Dragovich, PS Webber, SE Prins, TJ Zhou, R Marakovits, JT Tikhe, JG Fuhrman, SA Patick, AK Matthews, DA Ford, CE Brown, EL Binford, SL Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids, BIOORG MED, 9(15), 1999, pp. 2189-2194
Genomic mapping and evolution of human GABA(A) receptor subunit gene clusters
Authors: Bailey, MES Matthews, DA Riley, BP Albrecht, BE Kostrzewa, M Hicks, AA Harris, R Muller, U Darlinson, MG Johnson, KJ
Citation: Mes. Bailey et al., Genomic mapping and evolution of human GABA(A) receptor subunit gene clusters, MAMM GENOME, 10(8), 1999, pp. 839-843
A new look at the molecular mechanism of thymidylate synthase and its interaction with nucleotide analogues
Authors: Kalman, TI Matthews, DA
Citation: Ti. Kalman et Da. Matthews, A new look at the molecular mechanism of thymidylate synthase and its interaction with nucleotide analogues, NUCLEOS NUC, 18(4-5), 1999, pp. 843-844
The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation
Authors: Petersen-Mahrt, SK Estmer, C Ohrmalm, C Matthews, DA Russell, WC Akusjarvi, G
Citation: Sk. Petersen-mahrt et al., The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation, EMBO J, 18(4), 1999, pp. 1014-1024
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease
Authors: Patick, AK Binford, SL Brothers, MA Jackson, RL Ford, CE Diem, MD Maldonado, F Dragovich, PS Zhou, R Prins, TJ Fuhrman, SA Meador, JW Zalman, LS Matthews, DA Worland, ST
Citation: Ak. Patick et al., In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease, ANTIM AG CH, 43(10), 1999, pp. 2444-2450
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
Authors: Matthews, DA Dragovich, PS Webber, SE Fuhrman, SA Patick, AK Zalman, LS Hendrickson, TF Love, RA Prins, TJ Marakovits, JT Zhou, R Tikhe, J Ford, CE Meador, JW Ferre, RA Brown, EL Binford, SL Brothers, MA DeLisle, DM Worland, ST
Citation: Da. Matthews et al., Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes, P NAS US, 96(20), 1999, pp. 11000-11007
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics
Authors: Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Ford, CE Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics, J MED CHEM, 42(7), 1999, pp. 1203-1212
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements
Authors: Dragovich, PS Prins, TJ Zhou, R Webber, SE Marakovits, JT Fuhrman, SA Patick, AK Matthews, DA Lee, CA Ford, CE Burke, BJ Rejto, PA Hendrickson, TF Tuntland, T Brown, EL Meador, JW Ferre, RA Harr, JEV Kosa, MB Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements, J MED CHEM, 42(7), 1999, pp. 1213-1224
Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein
Authors: Matthews, DA Cummings, D Evelegh, C Graham, FL Prevec, L
Citation: Da. Matthews et al., Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein, J GEN VIROL, 80, 1999, pp. 345-353
Risultati: 1-22 |